Mochi Health

Mochi Health publishes membership, support and supplier information through its official FAQ and company posts.

Named operator, an attributed physical business address and a working-purpose contact telephone. Distinguish registered or correspondence offices from clinical and dispensing locations; online care does not require a walk-in clinic. Weight: 8%.

The FAQ describes virtual providers and follow-up. Named clinicians were not matched to state licensing records.

Who the service is for, prescribing or research-use boundaries, and provider information. Weight: 5%.

The FAQ separates membership tiers and medication costs and states that medication shipping is included.

Public prices or a defined quotation process, with recurring or additional charges explained. Weight: 5%.

Cancel before renewal through the account or by telephone; email is not a valid cancellation method. Cancellation takes effect at the end of the paid term. No partial membership refunds; discretionary exceptions have limits. Prescription sales are final, with dispensing errors referred for investigation. No transaction or refund request was made.

Accessible cancellation, refund or ordering terms and a support channel. Weight: 4%.

Mochi names Aequita in its quality-report post. The post discusses regulatory concerns; it is not independent certification.

Named dispensing partners for care services; analytical documentation or manufacturing information for research businesses. Weight: 10%.

An entity-specific regulatory assessment has not been completed. No clean record or adverse finding is inferred.

Entity/product-specific regulatory notices, enforcement, recalls and their resolution, with dates and jurisdiction. A pharmacy license match alone is not a regulatory-history review. No clean record is inferred from silence. Weight: 10%.

This criterion has not yet been established from the reviewed evidence.

Product- and lot-specific laboratory reports covering molecule identity and purity, with the laboratory, report date and issuer authenticity check. Full credit requires independently established laboratory identity and a traceable verified report. A testing policy or a report for another batch provides limited evidence only; purity does not establish sterility, endotoxin control or treatment safety. Weight: 12%.

This criterion has not yet been established from the reviewed evidence.

An applicable external accreditation, such as LegitScript for healthcare, matched to the exact business or domain in the issuer’s records. A badge alone does not establish current certification. Weight: 3%.

This criterion has not yet been established from the reviewed evidence.

Accessible privacy terms identifying the responsible entities, data uses and applicable health-data notice. A HIPAA claim is not independent verification of compliance; HIPAA is not required of every research business. Weight: 6%.

This criterion has not yet been established from the reviewed evidence.

Specific, dated evidence of relevant security practices or an independently issued audit, with its entity, scope and limits. HTTPS, a marketing seal or a claim of being unhackable is insufficient. Weight: 6%.

This criterion has not yet been established from the reviewed evidence.

Disclosed payment processing, billing authorization and recurring-charge arrangements. No processor brand is preferred and a processor does not certify the provider’s clinical or product quality. Weight: 3%.

This criterion has not yet been established from the reviewed evidence.

Clear product identity and intended use, distinguishing branded medicines, compounded preparations and research materials; presentation and preparation requirements where relevant. A compounded product is not assumed to be an approved generic. Weight: 8%.

This criterion has not yet been established from the reviewed evidence.

Product-specific delivery, temperature and storage instructions, including handling of shipping problems. Refrigeration, freezing or a particular presentation receives no automatic quality bonus. Weight: 5%.

Mochi names Aequita. Oklahoma 99-9675 is CLOSED (end date January 30, 2026); this does not establish closure elsewhere. Washington facility lookup requires an interactive CAPTCHA. The open provider dataset is not a facility register, so an empty search cannot establish absence of a license. No active facility license was obtained.

At least one exactly named dispensing partner matched to an active, unreplaced official state record. This does not verify all partners or all jurisdictions. Weight: 15%.